A Phase 2b Study of Baricitinib in Participants With Moderate to Severe Psoriasis
PHASE2
This is a dose-ranging study designed to investigate the efficacy and safet...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Adaptive Platform Trial for Personnalisation of Sepsis Treatment in Children and Adults: a Multi-national, Treatable Traits-guided, Adaptive, Exploratory, Bayesian Basket Trial
PHASE2
PALETTE is a perpetual adaptive platform to efficiently study sepsis interv...